CD44 and breast carcinoma: CD44–hyaluronan interactions have been suggested to take place in the lipid rafts of breast cancer cells to facilitate oncogenic signalling [16], while CD44 interactions with the cytoplasmic binding partner merlin have been shown to inhibit cancer cell growth [17].